However, lymph node cells from LY2 tumor-bearing mice stimulated with the IR LY2 tumor cell antigen ex vivo demonstrated increased secretion of IL-4 compared to non-tumor-bearing mice, as determined by cytokine ELISA (Figure 5C). The gene discussed is IL4; the disease is neoplasm.